A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: First report of the Children's Cancer Group-0952 Article

Sanghavi, SN, Needle, MN, Krailo, MD et al. (2003). A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: First report of the Children's Cancer Group-0952 . NEURO-ONCOLOGY, 5(1), 8-13. 10.1215/S1522851702000108

Open Access Industry Collaboration

cited authors

  • Sanghavi, SN; Needle, MN; Krailo, MD; Geyer, JR; Ater, J; Mehta, MP

sustainable development goals

authors

publication date

  • January 1, 2003

published in

keywords

  • CELLS
  • Clinical Neurology
  • HYPERFRACTIONATED RADIATION-THERAPY
  • INHIBITOR
  • IONIZING-RADIATION
  • IRRADIATION
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PEDIATRIC-ONCOLOGY-GROUP
  • RADIOTHERAPY
  • STEM TUMORS
  • Science & Technology
  • TOPOISOMERASE-I
  • TRIAL

Digital Object Identifier (DOI)

publisher

  • CARDEN JENNINGS PUBL CO LTD

start page

  • 8

end page

  • 13

volume

  • 5

issue

  • 1